BioCryst Pharmaceuticals, Inc. (BCRX)
7.955
-0.14
(-1.79%)
USD |
NASDAQ |
Oct 06, 16:00
7.955
0.00 (0.00%)
After-Hours: 19:05
BioCryst Pharmaceuticals Total Return Level : 8.10 for Oct. 5, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 05, 2026 | 8.10 |
| October 02, 2026 | 8.17 |
| October 01, 2026 | 8.12 |
| September 30, 2026 | 8.33 |
| September 29, 2026 | 8.27 |
| September 28, 2026 | 8.47 |
| September 25, 2026 | 8.59 |
| September 24, 2026 | 8.52 |
| September 23, 2026 | 8.57 |
| September 22, 2026 | 8.78 |
| September 21, 2026 | 8.76 |
| September 18, 2026 | 8.68 |
| September 17, 2026 | 8.70 |
| September 16, 2026 | 8.43 |
| September 15, 2026 | 8.16 |
| September 14, 2026 | 8.23 |
| September 11, 2026 | 8.12 |
| September 10, 2026 | 8.29 |
| September 09, 2026 | 8.805 |
| September 08, 2026 | 9.065 |
| September 04, 2026 | 9.96 |
| September 03, 2026 | 10.09 |
| September 02, 2026 | 10.17 |
| September 01, 2026 | 9.92 |
| August 31, 2026 | 9.70 |
| Date | Value |
|---|---|
| August 28, 2026 | 9.82 |
| August 27, 2026 | 9.87 |
| August 26, 2026 | 9.83 |
| August 25, 2026 | 9.83 |
| August 24, 2026 | 9.68 |
| August 21, 2026 | 9.55 |
| August 20, 2026 | 9.66 |
| August 19, 2026 | 10.07 |
| August 18, 2026 | 9.70 |
| August 17, 2026 | 9.94 |
| August 14, 2026 | 9.74 |
| August 13, 2026 | 9.81 |
| August 12, 2026 | 10.59 |
| August 11, 2026 | 10.34 |
| August 10, 2026 | 9.84 |
| August 07, 2026 | 9.38 |
| August 06, 2026 | 9.30 |
| August 05, 2026 | 9.07 |
| August 04, 2026 | 9.02 |
| August 03, 2026 | 8.81 |
| July 31, 2026 | 8.98 |
| July 30, 2026 | 9.24 |
| July 29, 2026 | 9.53 |
| July 28, 2026 | 9.74 |
| July 27, 2026 | 9.58 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Amgen, Inc. | 603.43 |
| Halozyme Therapeutics, Inc. | 108.31 |
| Neurocrine Biosciences, Inc. | 144.21 |
| Vertex Pharmaceuticals, Inc. | 503.50 |
| Agenus, Inc. | 8.73 |